December 22, 2025 - Health Technology Insights

December 22, 2025
HealthTech Media Room
HealthTech News, News, news

China Approves Abbisko’s Pimicotinib for Tenosynovial Giant Cell Tumor

Based on the positive global Phase III MANEUVER study, the National Medical Products Administration (NMPA) has granted the world’s first regulatory approval for pimicotinib, the first domestically developed systemic...

December 22, 2025
HealthTech Media Room
HealthTech News, News, news

Atea Completes Phase 3 Enrollment for Hepatitis C Treatment

Enrollment Completed in C-BEYOND Phase 3 Trial with More Than 880 HCV Treatment-Naïve Patients in US and Canada Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company engaged in the discovery...

December 22, 2025
HealthTech Media Room
HealthTech News, News, news

CoRegen Adds Surgeon-Scientist Bert O’Malley Jr. to Board

CoRegen, Inc., a biopharmaceutical company pursuing novel treatments for patients impacted by some of the most aggressive forms of solid tumor cancer, announced the appointment of Bert W. O’Malley,...

December 22, 2025
HealthTech Media Room
HealthTech News, News, news

SCIENTURE Launches FDA-Approved High-Strength REZENOPY

SCIENTURE HOLDINGS, INC. a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through the development, commercialization, and distribution of...

December 22, 2025
HealthTech Media Room
HealthTech News, News, news

Samsung Biologics Acquires Human Genome Sciences from GSK

Samsung Biologics a leading contract development and manufacturing organization (CDMO), announced that its wholly owned U.S. subsidiary, Samsung Biologics America, has entered into a definitive agreement to acquire 100%...

December 22, 2025
HealthTech Media Room
HealthTech News, News, news

OsteoCentric Technologies Appoints Matthew Collier to Board of Directors

OsteoCentric Technologies announced the appointment of Matthew Collier to its Board of Directors, further strengthening the company’s leadership as it advances UnifiMI, a platform technology engineered for stable and durable mechanical...

December 22, 2025
HealthTech Media Room
HealthTech News, news, News

Datma and Rhythm Biosciences Partner on Genomic Data Collaboration

Datma, a leader in federated real-world data access, and Rhythm Biosciences Ltd, a developer of predictive cancer diagnostics including its geneType risk assessment portfolio, announced a new collaboration to...

December 22, 2025
HealthTech Media Room
HealthTech News, News, news

ZOLL Launches Fifth-Generation LifeVest WCD

ZOLL, an Asahi Kasei company specializing in medical devices and software solutions, has announced the U.S. release of the next generation LifeVest wearable cardioverter defibrillator. This launch marks the...

December 22, 2025
HealthTech Media Room
HealthTech News, News, news

Swisslog Healthcare Appoints Maria Garces as Vice President of Product Management

Swisslog Healthcare, a leading supplier of transport and pharmacy automation solutions, announces the appointment of Maria Garces as Vice President of Product Management. Garces brings deep experience in global product management,...

December 22, 2025
HealthTech Media Room
HealthTech News, News, news

Bristol Myers Squibb Partners with U.S. to Boost Drug Access

Bristol Myers Squibb, has reached an agreement with the U.S. government to provide Eliquis, a widely used oral anticoagulant, to the Medicaid program at no cost and to donate...

December 22, 2025
HealthTech Media Room
HealthTech News, News, news

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Pulse Biosciences, Inc., known for its innovative nPulse technology using Nanosecond Pulsed Field Ablation energy, announced that its Board of Directors’ Compensation Committee has approved equity inducement awards for...

December 22, 2025
HealthTech Staff Writer
HealthTech News, News, news

GenSight Biologics Gets CUA for GS010/LUMEVOQ in France

GenSight Biologics, a biopharma company listed on Euronext (SIGHT) and dedicated to developing gene therapies for retinal neurodegenerative and central nervous system disorders, has announced that the French health...